Study guide

13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

Certified Burn Registered Nurse CBRN

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Foundations of Burn Care

1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones

2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response

2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology

3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria

3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics

4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)

4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy

5 Chapter 5: Airway Management & Inhalation Injury Management

5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)

6 Chapter 6: Acute Multisystem Assessment & Critical Care Management

6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection

7 Chapter 7: Hypermetabolism & Nutritional Support

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation

8 Chapter 8: Pain Management in Burn Care

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction

9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus

9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients

10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings

10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances

11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure

11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy

12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion

13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries

13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

14 Chapter 14: Special Burn Populations & Cutaneous Syndromes

14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries

15 Chapter 15: Rehabilitation, Scar Management & Reconstruction

15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management

16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage

16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response

13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

Key Takeaways Explain This Topic AI

Cutaneous Radiation Syndrome (CRS) results from ionizing radiation-induced DNA double-strand breaks and microvascular endarteritis in basal keratinocytes, evolving through four classic chronological phases: Prodromal (early erythema/pruritus within hours), Latent (asymptomatic period lasting days to weeks), Manifest illness (severe erythema, epilation, moist desquamation, ischemic ulceration), and Late chronic (fibrosis, telangiectasia, radionecrosis, malignancy).

Frostbite pathogenesis involves a two-phase injury: direct cold-induced intracellular/extracellular ice crystal formation causing cellular dehydration and mechanical lysis, followed upon thawing by severe reperfusion injury characterized by microvascular endothelial destruction, thromboxane-mediated vasoconstriction, platelet-leukocyte aggregation, and progressive thrombosis.

Frostbite is classified into four degrees: 1st degree (frostnip, erythema, edema, no blisters), 2nd degree (superficial clear fluid blisters with intact sensation), 3rd degree (deep hemorrhagic/violaceous blisters with blue-gray skin and loss of sensation), and 4th degree (complete full-thickness freezing through muscle, tendon, and bone resulting in mummification and dry gangrene).

Rapid active rewarming protocols strictly prohibit rubbing, dry radiant heat, or premature thawing if any risk of refreezing exists (refreezing causes catastrophic, irreversible tissue death); rewarming must occur in a circulating warm water bath maintained at precisely 37°C to 39°C (98.6°F to 102.2°F) for 15 to 30 minutes until tissues become soft, pliable, and erythematous.

Advanced post-thaw therapy incorporates thrombolysis (IV or catheter-directed intra-arterial tissue plasminogen activator [tPA] within 24 hours of thawing), prostacyclin vasodilators (Iloprost), and strict adherence to delayed surgical amputation ('freeze in January, amputate in July') to permit complete demarcation over 1 to 3 months.

Last updated: August 2026

13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

Core Knowledge: Cutaneous radiation syndrome (CRS) and cold injuries (frostbite) represent distinct physical trauma etiologies encountered in specialized burn intensive care units. Both entities share a common pathophysiological theme: delayed clinical manifestation of deep microvascular occlusion following an initial physical insult. Mastering the chronological stages of radiation injury, the biophysical principles of cellular freezing, evidence-based rapid rewarming protocols, and modern microvascular salvage therapies (tPA and prostacyclin analogues) is essential for the Certified Burn Registered Nurse.

1. Radiation Injuries and Cutaneous Radiation Syndrome (CRS)

Ionizing radiation (alpha particles, beta particles, gamma rays, and high-energy industrial X-rays) damages living tissue through the radiolysis of intracellular water, producing reactive oxygen species (ROS) that induce double-stranded DNA breaks. The most radiosensitive cells in the integumentary system are rapidly proliferating basal layer keratinocytes and microvascular endothelial cells . CUTANEOUS RADIATION SYNDROME (CRS) PHASES

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ 1. PRODROMAL PHASE (Hours to Days post-exposure): │
  • │ • Transient erythema, warmth, pruritus, tingling, and localized edema. │
  • │ • Driven by histamine, prostaglandin, and cytokine release. │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ 2. LATENT PHASE (Days to several Weeks post-exposure): │
  • │ • Asymptomatic 'quiescent' window; skin appears to recover. │
  • │ • Deceptive lull while progressive microvascular obliterative │
  • │ endarteritis and basal stem cell death progress unseen. │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ 3. MANIFEST ILLNESS PHASE (Weeks to Months post-exposure): │
  • │ • Dose-dependent tissue breakdown: │
  • │ - Epilation / Hair Loss (>3 Gy) │
  • │ - Erythema & Dry Desquamation (>8–10 Gy) │
  • │ - Moist Desquamation & Bullae (>12–15 Gy) │
  • │ - Deep Ischemic Ulceration & Radionecrosis (>20–25 Gy) │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ 4. LATE CHRONIC PHASE (Months to Years post-exposure): │
  • │ • Dermal atrophy, dense subcutaneous fibrosis, telangiectasias, │
  • │ non-healing intractable ischemic ulcers, and secondary malignancies. │
  • └────────────────────────────────────────────────────────────────────────┘

Clinical Management of Radiation Burns:

Decontamination: If external radionuclide contamination is present, patients must undergo thorough washing with warm water and mild soap; effluent water must be contained to prevent hazardous environmental spread.

Wound Care and Barrier Protection: Irradiated skin is prone to microvascular insufficiency and infection. Non-adherent silicone dressings, topical antimicrobials, and avoidance of mechanical trauma are essential.

Surgical Principles: Standard surgical debridement often fails in radiation wounds because surrounding tissue margins suffer from obliterative endarteritis with zero healing potential. Surgical reconstruction mandates wide radical excision back to well-vascularized tissue combined with vascularized free-tissue flap transfer or autologous stem-cell therapies.

2. Frostbite Pathophysiology: Cellular Freezing and Reperfusion Injury

Frostbite is a localized cold-induced injury characterized by tissue freezing. Its destructive process unfolds across two distinct pathophysiological phases: BIPHASIC FROSTBITE PATHOPHYSIOLOGY

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ PHASE 1: DIRECT COLD-INDUCED CELLULAR DAMAGE (Freezing Phase) │
  • │ • Extracellular fluid freezes at -2°C (28.4°F), forming ice crystals. │
  • │ • Water shifts osmotically from inside cells to the extracellular space│
  • │ causing severe cellular dehydration and hyperosmolality. │
  • │ • Intracellular ice crystals form mechanically, piercing and shearing │
  • │ plasma membranes and organelles, causing irreversible cell lysis. │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ PHASE 2: PROGRESSIVE MICROVASCULAR THROMBOSIS (Reperfusion Phase) │
  • │ • Upon thawing, damaged vascular endothelial cells swell and release │
  • │ massive quantities of Thromboxane A₂ (TXA₂) and Prostaglandin F₂α. │
  • │ • Intense vasoconstriction, platelet aggregation, and leukocyte │
  • │ sludging generate progressive microthrombi in capillary beds. │
  • │ • Reperfusion reactive oxygen species (ROS) accelerate microvascular │
  • │ stasis, leading to progressive tissue ischemia and dry gangrene. │
  • └────────────────────────────────────────────────────────────────────────┘
  • 3. Frostbite Classification and Staging

Frostbite is staged clinically into four degrees based on depth of freezing, blister characteristics, and sensory status following rewarming:

Degree Depth of Injury Clinical Presentation Post-Thaw Blister Characteristics & Prognosis

1st Degree (Frostnip) Superficial epidermis Central pallor, numbness, surrounding erythema, edema; no blister formation. No blisters; desquamation at 5–10 days; excellent prognosis with no tissue loss.

2nd Degree Full-thickness epidermis & superficial dermis Hyperemia, substantial edema, intact dermal sensation to light touch/pinprick. Large clear or milky fluid-filled blisters extending to digit tips; good prognosis.

3rd Degree Deep reticular dermis & subcutaneous tissue Hard, cold, blue-gray/violaceous skin; complete loss of sensation; severe throbbing pain. Hemorrhagic (dark purple/black) blisters with surrounding edema; poor prognosis; partial tissue loss.

4th Degree Bone, muscle, and tendon Mottled, cyanotic, cold, pulseless, non-blanching; completely insensate. Absence of blisters; rapid dry mummification and black gangrene; inevitable amputation. CLEAR VS. HEMORRHAGIC BLISTERS

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ • Clear / Milky Blisters (2nd Degree): Subepidermal cleavage above the │
  • │ dermal vascular plexus; indicates underlying viable microvasculature.│
  • │ • Hemorrhagic / Dark Blisters (3rd Degree): Subdermal cleavage below │
  • │ the vascular plexus; indicates deep microvascular thrombosis and │
  • │ dermal vascular bed necrosis. │
  • └────────────────────────────────────────────────────────────────────────┘
  • 4. Evidence-Based Frostbite Rewarming Protocols

Proper pre-hospital and hospital rewarming protocols represent the single most important determinant of tissue preservation in cold injuries. CARDINAL RULES OF FROSTBITE RESCUE

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ 1. NEVER THAW IF RISK OF REFREEZING EXISTS: │
  • │ If a patient is in a wilderness/evacuation setting where refreezing │
  • │ is possible, DO NOT attempt to thaw. Walking on frozen feet causes │
  • │ far less tissue loss than walking on thawed, refrozen tissue. │
  • │ A freeze-thaw-refreeze cycle causes catastrophic, 100% tissue death.│
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ 2. NEVER RUB OR MASSAGE FROZEN TISSUES: │
  • │ Rubbing with snow or hands mechanically grinds internal ice crystals│
  • │ against fragile cell membranes, lacerating microstructures. │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ 3. NEVER USE DRY RADIANT HEAT: │
  • │ Campfires, car heaters, hair dryers, and hot water bottles cause │
  • │ severe thermal burns because the frostbitten skin is insensate. │
  • └────────────────────────────────────────────────────────────────────────┘

Standard Active Rapid Rewarming Protocol:

Circulating Water Bath: Immerse the affected extremity in a clean, circulating water bath maintained at precisely 37°C to 39°C (98.6°F to 102.2°F) . Temperatures > 40 ∘ C >40^\circ\text{C} > 4 0 ∘ C cause severe thermal burns to ischemic tissue, whereas temperatures < 37 ∘ C <37^\circ\text{C} < 3 7 ∘ C delay rewarming and increase microvascular thrombosis.

Duration: Continue immersion for 15 to 30 minutes (or until the distal extremity becomes soft, pliable, and develops a deep red or purple erythematous flush).

Analgesia: Rapid active thawing produces excruciating, ischemic reperfusion pain. The nurse must proactively administer intravenous opioids (e.g., fentanyl, morphine) and scheduled NSAIDs (ibuprofen 400 – 800 mg 400\text{--}800\text{ mg} 400 – 800 mg to inhibit thromboxane A 2 A_2 A 2 ​ synthesis).

Post-Thaw Care: Apply topical aloe vera cream (thromboxane inhibitor); dress digits individually with bulky, non-adherent sterile cotton gauze; elevate extremities above heart level to reduce edema; verify tetanus vaccination status.

5. Advanced Thrombolysis, Vasodilator Therapy, and Delayed Demarcation

Modern burn center protocols utilize advanced microvascular pharmacotherapy within the early therapeutic window to prevent digit and limb loss in deep frostbite (2nd–4th degree). ADVANCED FROSTBITE SALVAGE MATRIX

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ THROMBOLYTIC THERAPY (tPA Protocol): │
  • │ • Therapeutic Window: Within 24 HOURS of rewarming. │
  • │ • Indications: Severe frostbite with absent distal arterial flow on │
  • │ Doppler, angiography, or technetium-99m (Tc-99m) bone scintigraphy. │
  • │ • Agents: IV or catheter-directed intra-arterial (IA) tissue │
  • │ plasminogen activator (Alteplase) + continuous IV unfractionated │
  • │ heparin. Dissolves microvascular fibrin thrombi. │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ PROSTACYCLIN VASODILATOR THERAPY (Iloprost Protocol): │
  • │ • Agent: Iloprost (prostacyclin analogue, PGI₂). │
  • │ • Mechanism: Potent microvascular vasodilator; suppresses platelet │
  • │ aggregation and leukocyte adhesion; restores distal perfusion. │
  • │ • Regimen: Continuous IV infusion for 6 hours daily over 5–8 days. │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ SURGICAL PRINCIPLE: DELAYED SURGICAL AMPUTATION │
  • │ • Traditional Maxim: 'Freeze in January, amputate in July.' │
  • │ • Premature debridement or surgical amputation is strictly avoided. │
  • │ • Ischemic black eschars take 1 to 3 MONTHS to fully mummify and clear │
  • │ demarcate; underlying viable dermis often regenerates beneath. │
  • │ • Emergent surgery is indicated ONLY for invasive wet gangrene/sepsis. │
  • └────────────────────────────────────────────────────────────────────────┘